<!DOCTYPE html>

<html>
<head>
<meta charset="utf-8"/>
<meta content="width=device-width, initial-scale=1.0" name="viewport"/>
<link href="../../../webpages.css" rel="stylesheet"/>
</head>
<body>
<div class="banner">
<div class="banner-content">
<h1>DermpathNet</h1>
</div>
</div>
<nav>
<a href="../../../index.html" target="_blank">
<text type="button">Home</text>
</a>
<a href="../../../browser-page-317.html" target="_blank">
<text type="button">Browse</text>
</a>
<a href="../../../download-page.html" target="_blank">
<text type="button">Downloads</text>
</a>
<a href="../../../contact-us.html" target="_blank">
<text type="button">About</text>
</a>
</nav>
<footer class="site-footer">
<p>@2024 New York University Grossman School of Medicine, Weill Cornell Medicine</p>
<!--<p>Privacy Policy | Terms of Service | Cookie Policy</p>-->
</footer>
<title>Regression of metastatic melanoma in a patient by antibody targeting of cancer stem cells.-DermPath</title>
<div class="content-container"> <div class="figures-container"> <div class="image-side"> <img alt="Regression of metastatic melanoma in a patient by antibody targeting of cancer stem cells." class="clickable-image" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/420e/3292889/68c4a5f76eeb/oncotarget-03-022-g001.jpg"/> </div> <div class="text-side"> <h1>Regression of metastatic melanoma in a patient by antibody targeting of cancer stem cells.</h1> <p>Rituximab treatment reduced the number of CD20+ melanoma cells in treated metastasesMetastatic melanoma lesions harbor CD20+ melanoma cells. Cryostat sections of a cutaneous metastatic melanoma lesion prior and after rituximab treatment were stained for CD20 and visualized by peroxidase-AEC reaction. The biopsy after rituximab treatment was taken from the same melanoma lesion but distant from first biopsy. Staining with an isotype matched antibody of irrelevant specificity served as control. Hematoxylin-eosin (H&amp;E) staining shows the histology. Of note, rituximab binding does not interfere with staining by the anti-CD20 antibody used in this analysis.</p> <p>PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/22289880/" target="_blank">22289880</a></p><p>Type: Premalignant/Malignant, Category: Melanocytic</p>
</div> </div></div></body></html>